Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

U.S. Parkinson's Disease Therapies Markets

U.S. Parkinson's Disease Therapies Markets

 

RELEASE DATE
06-Aug-2003
REGION
North America
Research Code: A232-01-00-00-00
SKU: HC00840-NA-MR_04546
AvailableYesPDF Download

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
HC00840-NA-MR_04546

$2,450.00

$1,837.50save 25 %

DownloadLink
Add to Compare
ENQUIRE NOW

Description

This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. The market is segmented into dopamine agonists, levodopa / carbidopa, and other drugs for parkinson's disease. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.

Table of Contents

Executive Summary

  • Executive Summary

Disease Overview

  • Report Scope
  • Overview
  • Prevalence and Incidence
  • Clinical Presentation
  • Diagnosis

Treatment Overview

  • Evolution of PD Therapy
  • Surgical and Related Options
  • Guidelines for Management of PD
  • Product and Pricing Analysis

Market Dynamics

Market Engineering Analysis

  • Major Market Drivers
  • Major Market Restraints
  • Market Challenges and Strategies

Competitive Analysis

  • Market Overview
  • Market Engineering Measurements

Forecasts and Trends

  • Major Market Participants
  • Competitive Structure

Frost & Sullivan Awards

  • Disease Progression Stages
  • Impact of Current Scenario
  • Impact of New Products
  • Patient Forecasts
  • Revenue Forecasts

Current Drugs

Market Dynamics and Forecasts

Current Drugs

Market Dynamics and Forecasts

Current Products and Pricing

Market Dynamics and Forecasts

Pipeline Analysis

Request Sample
Popular Topics

neuromodulation market

astaxanthin market

functional food market

ridesharing market

nanophotonic equipment market

telematics market

medical robots market

neurology devices market

aerospace industry outlook

wearable electronics market

This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. The market is segmented into dopamine agonists, levodopa / carbidopa, and other drugs for parkinson's disease. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number A232-01-00-00-00
Is Prebook No